Texas Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that outlines the terms and conditions for the use of certain intellectual property rights and technologies developed by the University. This agreement serves to protect the interests of both parties involved while promoting the transfer and commercialization of innovative technologies. Gentling, Inc., a biotechnology company, enters into this collaboration with the University to access and further develop research advancements made by the University's Health Science Center. The Collateral License Agreement allows Gentling, Inc. to gain limited rights to use the University's intellectual property, including patents, trademarks, copyrights, and know-how related to specific technologies or inventions. The license agreement states the scope of usage, territories, timeframe, and any other relevant restrictions or conditions for the use of these intellectual properties. The agreement typically includes provisions for the payment of royalties or other financial considerations from Gentling, Inc. to the University in exchange for the granted license. These financial arrangements ensure that both parties benefit from the commercialization of the licensed technologies. Different types of Texas Collateral License Agreement may exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific technologies involved. For example: 1. Patent License Agreement: This type of collateral license agreement grants Gentling, Inc. the rights to use the University-owned patents for the development, manufacturing, and commercialization of specific products or technologies. 2. Copyright License Agreement: In cases where the University owns copyrights for certain software, artistic works, or written materials, this type of agreement allows Gentling, Inc. to use, modify, distribute, or sublicense these copyrighted materials. 3. Trademark License Agreement: If the University owns trademarks associated with a particular technology or product, this agreement permits Gentling, Inc. to use and display these trademarks in their marketing materials, packaging, or distribution efforts. It's important to note that the exact terms and conditions of each Texas Collateral License Agreement may vary depending on the negotiation between Gentling, Inc. and The University of North Texas Health Science Center, as well as the specific technologies involved.

The Texas Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal agreement that outlines the terms and conditions for the use of certain intellectual property rights and technologies developed by the University. This agreement serves to protect the interests of both parties involved while promoting the transfer and commercialization of innovative technologies. Gentling, Inc., a biotechnology company, enters into this collaboration with the University to access and further develop research advancements made by the University's Health Science Center. The Collateral License Agreement allows Gentling, Inc. to gain limited rights to use the University's intellectual property, including patents, trademarks, copyrights, and know-how related to specific technologies or inventions. The license agreement states the scope of usage, territories, timeframe, and any other relevant restrictions or conditions for the use of these intellectual properties. The agreement typically includes provisions for the payment of royalties or other financial considerations from Gentling, Inc. to the University in exchange for the granted license. These financial arrangements ensure that both parties benefit from the commercialization of the licensed technologies. Different types of Texas Collateral License Agreement may exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific technologies involved. For example: 1. Patent License Agreement: This type of collateral license agreement grants Gentling, Inc. the rights to use the University-owned patents for the development, manufacturing, and commercialization of specific products or technologies. 2. Copyright License Agreement: In cases where the University owns copyrights for certain software, artistic works, or written materials, this type of agreement allows Gentling, Inc. to use, modify, distribute, or sublicense these copyrighted materials. 3. Trademark License Agreement: If the University owns trademarks associated with a particular technology or product, this agreement permits Gentling, Inc. to use and display these trademarks in their marketing materials, packaging, or distribution efforts. It's important to note that the exact terms and conditions of each Texas Collateral License Agreement may vary depending on the negotiation between Gentling, Inc. and The University of North Texas Health Science Center, as well as the specific technologies involved.